Bradizza | Stasiewicz | Lucke | Coffey | Gulliver
Researchers will study the effectiveness of Affect Regulation Treatment (ART) as an intervention for people with alcohol use disorders.

Despite the strong links between positive and negative affect situations and problem drinking, few studies have directly addressed whether interventions that target affect regulation positively impact drinking outcomes. This study proposes to conduct a fully-powered Stage II efficacy trial to compare an Affect Regulation Treatment (ART) supplement to a standard cognitive-behavioral (CBT) intervention for alcohol use disorder to an active health and lifestyle control supplement to CBT and explore mechanisms of action by which ART exerts its positive effects. If successful, the findings from this study are anticipated to have a direct impact on clinical practice by providing the field with a novel, effective treatment for alcohol use disorders that addresses affect regulation difficulties.

Principal Investigators
Clara Bradizza, PhD
Clinical and Research Institute on Addictions
Department of Psychiatry

Paul Stasiewicz, PhD
Clinical and Research Institute on Addictions
Department of Psychiatry

Co-Investigators
Joseph Lucke, PhD
Clinical and Research Institute on Addictions

Scott Coffey, PhD
University of Mississippi Medical Center

Suzy Gulliver, PhD
Scott & White Memorial Hospital

Funding Agency
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Grant Number
R01-AA024628

Dates
2016-2021